Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis gets FDA nod for Tabrecta to treat metastatic NSCLC with METex14

pharmaceutical-business-reviewMay 11, 2020

Tag: Novartis , NSCLC , Tabrecta , METex14

PharmaSources Customer Service